Literature DB >> 10893453

Results and complications in 66 cases using a silicone tendon expander on overacting superior obliques with A- pattern anisotropias.

Z F Pollard1, M F Greenberg.   

Abstract

PURPOSE: To supplement limited reports in the literature of the results (outcome)and complications of this procedure with our own recent experience.
METHODS: A total of 66 patients with bilateral overaction of the superior oblique and A-pattern strabismus plus 5 patients with a unilateral overacting superior oblique secondary to inferior oblique palsy were treated with a 7 mm silicone expander.
RESULTS: The fist group of 66 patients had an average preoperative A-pattern of 39.6 prism diopters with an average correction of the A-pattern from the surgery of 36.3 prism diopters. COMPLICATIONS: Of all 137 operations in these 71 patients, three patients had a sterile orbital cellulitis postoperatively successfully treated with steroids. Also, one patient acquired a Brown's Syndrome-like condition postop'. In these four patients, the sub-Tenon's capsule space had been inadvertently entered during surgery. In addition one unilateral superior oblique palsy occurred postoperatively.
CONCLUSION: While this procedure has a very high success rate, special care should be taken with this surgery to avoid entering the sub-Tenon's capsule space.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893453

Source DB:  PubMed          Journal:  Binocul Vis Strabismus Q        ISSN: 1088-6281


  2 in total

1.  Superior oblique tendon lengthening and medial rectus transposition in the bilateral aplasia of the inferior rectus muscle: SO lengthening in the bilateral aplasia of IR.

Authors:  Ungsoo Samuel Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-17       Impact factor: 3.117

2.  Modified superior oblique intrasheath tenectomy in A-pattern with superior oblique overaction.

Authors:  Chunhua Sun; Ze Wang; Bo Xia
Journal:  BMC Ophthalmol       Date:  2021-04-21       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.